Authors:
Nielsen, HB
Kharazmi, A
Bolbjerg, ML
Poulsen, HE
Pedersen, BK
Secher, NH
Citation: Hb. Nielsen et al., N-acetylcysteine attenuates oxidative burst by neutrophils in response to ergometer rowing with no effect on pulmonary gas exchange, INT J SP M, 22(4), 2001, pp. 256-260
Authors:
Sairafianpour, M
Christensen, J
Staerk, D
Budnik, BA
Kharazmi, A
Bagherzadeh, K
Jaroszewski, JW
Citation: M. Sairafianpour et al., Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: New source of tanshinones, J NAT PROD, 64(11), 2001, pp. 1398-1403
Citation: Sb. Christensen et A. Kharazmi, Antimalarial natural products, BIOACTIVE COMPOUNDS FROM NATURAL SOURCES: ISOLATION CHARACTERISATION AND BIOLOGICAL PROPERTIES, 2001, pp. 379
Authors:
Dabiri, S
Meymandi, SS
Nadji, M
Kharazmi, A
Citation: S. Dabiri et al., A description of parasite-harbouring cells in localized lymphadenitis in dry type cutaneous leishmaniasis, ACT TROP, 79(2), 2001, pp. 129-133
Authors:
Christensen, CBV
Jorgensen, L
Jensen, ATR
Gasim, S
Chen, M
Kharazmi, A
Theander, TG
Andresen, K
Citation: Cbv. Christensen et al., Molecular characterization of a Leishmania donovanii cDNA clone with similarity to human 20S proteasome a-type subunit, BBA-MOL BAS, 1500(1), 2000, pp. 77-87
Authors:
Moser, C
Kjaergaard, S
Pressler, T
Kharazmi, A
Koch, C
Hoiby, N
Citation: C. Moser et al., The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type, APMIS, 108(5), 2000, pp. 329-335
Authors:
Staerk, D
Lemmich, E
Christensen, J
Kharazmi, A
Olsen, CE
Jaroszewski, JW
Citation: D. Staerk et al., Leishmanicidal, antiplasmodial and cytotoxic activity of indole alkaloids from Corynanthe pachyceras, PLANTA MED, 66(6), 2000, pp. 531-536
Authors:
Ajdary, S
Alimohammadian, MH
Eslami, MB
Kemp, K
Kharazmi, A
Citation: S. Ajdary et al., Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection, INFEC IMMUN, 68(4), 2000, pp. 1760-1764
Authors:
Ostergaard, C
Yieng-Kow, RV
Larsen, CG
Mukaida, N
Matsushima, K
Benfield, T
Frimodt-Moller, N
Espersen, F
Kharazmi, A
Lundgren, JD
Citation: C. Ostergaard et al., Treatment with a monoclonal antibody to IL-8 attenuates the pleocytosis inexperimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally, CLIN EXP IM, 122(2), 2000, pp. 207-211
Authors:
Gasim, S
Elhassan, AM
Kharazmi, A
Khalil, EAG
Ismail, A
Theander, TG
Citation: S. Gasim et al., The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclearcells (PBMC), CLIN EXP IM, 119(3), 2000, pp. 523-529
Authors:
Dabiri, S
Meymandi, SS
Hayes, MM
Soleimani, F
Kharazmi, A
Citation: S. Dabiri et al., Intralesional autotherapy of cutaneous leishmaniasis with buffy coat cells: cytological findings, ACT TROP, 75(1), 2000, pp. 1-7
Authors:
Gaafar, A
Veress, B
Permin, H
Kharazmi, A
Theander, TG
El Hassan, AM
Citation: A. Gaafar et al., Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major, CLIN IMMUNO, 91(3), 1999, pp. 314-320
Authors:
Mathee, K
Ciofu, O
Sternberg, C
Lindum, PW
Campbell, JIA
Jensen, P
Johnsen, AH
Givskov, M
Ohman, DE
Molin, S
Hoiby, N
Kharazmi, A
Citation: K. Mathee et al., Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung, MICROBIO-UK, 145, 1999, pp. 1349-1357
Authors:
Moser, C
Hougen, HP
Song, ZJ
Rygaard, J
Kharazmi, A
Hoiby, N
Citation: C. Moser et al., Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response, APMIS, 107(12), 1999, pp. 1093-1100
Authors:
Zhai, L
Chen, M
Blom, J
Theander, TG
Christensen, SB
Kharazmi, A
Citation: L. Zhai et al., The antileishmanial activity of novel oxygenated chalcones and their mechanism of action, J ANTIMICRO, 43(6), 1999, pp. 793-803
Authors:
Kemp, K
Theander, TG
Hviid, L
Garfar, A
Kharazmi, A
Kemp, M
Citation: K. Kemp et al., Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis, SC J IMMUN, 49(6), 1999, pp. 655-659
Authors:
Jensen, ATR
Gasim, S
Moller, T
Ismail, A
Gaafar, A
Kemp, M
El Hassan, AM
Kharazmi, A
Alce, TM
Smith, DF
Theander, TG
Citation: Atr. Jensen et al., Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L-donovani gene B protein (GBP) and a peptide sequence of L-donovani GBP, T RS TROP M, 93(2), 1999, pp. 157-160
Authors:
Sittie, AA
Lemmich, E
Olsen, CE
Hviid, L
Kharazmi, A
Nkrumah, FK
Christensen, SB
Citation: Aa. Sittie et al., Structure-activity studies: In vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida, PLANTA MED, 65(3), 1999, pp. 259-261